$72.86
1.03% yesterday
Nasdaq, Dec 08, 10:00 pm CET
ISIN
US8064071025
Symbol
HSIC

Henry Schein Stock price

$72.86
-0.14 0.19% 1M
+1.96 2.76% 6M
+3.66 5.29% YTD
-2.12 2.83% 1Y
-8.46 10.40% 3Y
+2.41 3.42% 5Y
+11.03 17.83% 10Y
+55.84 328.12% 20Y
Nasdaq, Closing price Mon, Dec 08 2025
-0.76 1.03%

New AI Insights on Henry Schein Insights AI Insights on Henry Schein

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$8.6b
Enterprise Value
$11.5b
Net debt
$3.0b
Cash
$136.0m
Shares outstanding
118.6m
Valuation (TTM | estimate)
P/E
22.6 | 14.5
P/S
0.7 | 0.6
EV/Sales
0.9 | 0.9
EV/FCF
32.4
P/B
2.6
Financial Health
Equity Ratio
33.2%
Return on Equity
11.5%
ROCE
9.7%
ROIC
6.1%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$12.9b | $13.3b
EBITDA
$1.0b | $1.1b
EBIT
$769.0m | $978.7m
Net Income
$391.0m | $594.7m
Free Cash Flow
$356.0m
Growth (TTM | estimate)
Revenue
3.5% | 4.6%
EBITDA
20.1% | 9.6%
EBIT
26.5% | 32.8%
Net Income
24.5% | 52.5%
Free Cash Flow
-9.0%
Margin (TTM | estimate)
Gross
31.2%
EBITDA
7.9% | 8.4%
EBIT
5.9%
Net
3.0% | 4.5%
Free Cash Flow
2.8%
More
EPS
$3.2
FCF per Share
$3.0
Short interest
7.0%
Employees
25k
Rev per Employee
$510.0k
Show more

Is Henry Schein a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Henry Schein Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Henry Schein forecast:

11x Buy
50%
9x Hold
41%
2x Sell
9%

Analyst Opinions

22 Analysts have issued a Henry Schein forecast:

Buy
50%
Hold
41%
Sell
9%

Financial data from Henry Schein

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
12,938 12,938
4% 4%
100%
- Direct Costs 8,903 8,903
4% 4%
69%
4,035 4,035
2% 2%
31%
- Selling and Administrative Expenses 3,009 3,009
3% 3%
23%
- Research and Development Expense - -
-
-
1,026 1,026
20% 20%
8%
- Depreciation and Amortization 257 257
4% 4%
2%
EBIT (Operating Income) EBIT 769 769
26% 26%
6%
Net Profit 391 391
25% 25%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Henry Schein directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Henry Schein Stock News

Positive
Seeking Alpha
3 days ago
Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong market share. HSIC continues to deliver solid growth, reporting Q3 revenue up 5.2% year-over-year and improved profitability across all segments, driven by internal growth and targeted programs. Management anticipates ongoing revenue and EBI...
Neutral
Seeking Alpha
6 days ago
Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Neutral
Business Wire
7 days ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the drill-free Curodont™ Repair Fluoride Plus (“Curodont”) product across all dental market segments, effective January 1, 2026. The strategic expansion broadens Henry Schein's previous exclusivity with th...
More Henry Schein News

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Head office United States
CEO Stanley Bergman
Employees 25,000
Founded 1932
Website www.henryschein.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today